The role of S100A4 gene encoding an S100-related calcium-binding protein in human bile duct adenocarcinoma cell lines: correlation of S100A4 expression and invasive growth in Matrigel Matrix.

Author(s):  
N Katayama ◽  
S Murao ◽  
T Ajiki ◽  
S Kitazawa ◽  
H Onoyama ◽  
...  
2013 ◽  
Vol 76 (2) ◽  
pp. 63-70 ◽  
Author(s):  
Kuan-Chong Chao ◽  
Peng-Hui Wang ◽  
Chi-Ching Chang ◽  
Ming-Shyen Yen ◽  
Chin-Wen Chi

Cancers ◽  
2019 ◽  
Vol 11 (7) ◽  
pp. 922 ◽  
Author(s):  
Olivier Mauduit ◽  
Vanessa Delcroix ◽  
Tom Lesluyes ◽  
Gaëlle Pérot ◽  
Pauline Lagarde ◽  
...  

Soft-tissue sarcomas (STS) are rare tumors whose oncogenesis remains unknown and for which no common therapeutic target has yet been identified. Analysis of 318 STS by CGH array evidenced a frequent deletion affecting the DMD gene (encoding dystrophin isoforms) in 16.5% of STS, including sarcomas with complex genomics, gastrointestinal tumors (GIST), and synovial sarcomas (SS). These deletions are significantly associated with metastatic progression, thus suggesting the role of DMD downregulation in the acquisition of aggressive phenotypes. We observed that targeted deletions of DMD were restricted to the 5’ region of the gene, which is responsible for the transcription of Dp427. Analysis of STS tumors and cell lines by RNA sequencing revealed that only the Dp71 isoform was widely expressed. Dp427 depletion had no effect on cell growth or migration. However, Dp71 inhibition by shRNA dramatically reduced the cell proliferation and clonogenicity of three STS cell lines, likely by altering the cell cycle progression through the G2/M-phase. Our work demonstrates that DMD deletions are not restricted to myogenic tumors and could be used as a biomarker for metastatic evolution in STS. Dp71 seems to play an essential role in tumor growth, thus providing a potential target for future STS treatments.


2003 ◽  
Vol 124 (4) ◽  
pp. A287
Author(s):  
Manabu Wada ◽  
Shojiro Yazumi ◽  
Shigeo Takaishi ◽  
Kazunori Hasegawa ◽  
Mitsutaka ◽  
...  

PLoS ONE ◽  
2015 ◽  
Vol 10 (3) ◽  
pp. e0120651 ◽  
Author(s):  
Alejandro Carozzo ◽  
Federico Diez ◽  
Natalia Gomez ◽  
Maia Cabrera ◽  
Carina Shayo ◽  
...  

1992 ◽  
Vol 51 (4) ◽  
pp. 274-280 ◽  
Author(s):  
Michihiko Tsubono ◽  
Yoshinori Nio ◽  
Chen-Chiu Tseng ◽  
Kazuya Kawabata ◽  
Yoshikazu Masai ◽  
...  

Author(s):  
Mila Ghosh ◽  
Naoto Koike ◽  
Shin-Ichi Tsunoda ◽  
Takashi Hirano ◽  
Sunil Kaul ◽  
...  

2003 ◽  
Vol 31 (1) ◽  
pp. 175-177 ◽  
Author(s):  
S. Kuchin ◽  
V.K. Vyas ◽  
M. Carlson

The sucrose non-fermenting 1 (Snf1) protein kinase of Saccharomyces cerevisiae is important for transcriptional, metabolic and developmental responses to glucose limitation. Here we discuss the role of the Snf1 kinase in regulating filamentous invasive growth. Haploid invasive growth occurs in response to glucose limitation and requires FLO11, a gene encoding a cell-surface adhesin. Snf1 regulates transcription of FLO11 by antagonizing the function of two repressors, Nrg1 and Nrg2. Snf1 and the Nrg repressors also affect diploid pseudohyphal differentiation, which is a response to nitrogen limitation, suggesting an unexpected signalling role for the Snf1 kinase.


2021 ◽  
Vol 11 ◽  
Author(s):  
Xuan Lu ◽  
Ningning Kang ◽  
Xinxin Ling ◽  
Ming Pan ◽  
Wenjing Du ◽  
...  

BackgroundFerroptosis is a newly generated regulatory cell death promoted by the accumulated lipid-based reactive oxygen species (ROS). Solute carrier family 7 member 11 (SLC7A11), the cystine/glutamate antiporter, is known as a ferroptosis executor that exhibits a positive correlation with carcinoma progression because of antioxidant function. Nonetheless, it is yet unclear on the understanding of ferroptosis regulation in lung cancer.MethodsDatabase, qRT-PCR, Western-blot (WB), and immunohistochemistry were utilized to determine SLC7A11 expression and function, as well as gene iron related to necrosis in clinical tissue specimens and cells; a ferroptosis inducer, inhibitors, and SLC7A11 lentivirus were used to confirm SLC7A11’s biological activity in cell viability, oxidative stress, lipid peroxidation, and iron ion enrichment in non-small cell lung cancer (NSCLC) in different cells; lentivirus was used to infect lung adenocarcinoma cell lines to acquire miR-27a-3p overexpression and knockdown cell lines, and to detect SLC7A11 level through qRT-PCR and WB. The influence of upregulated/downregulated miR-27a-3p on ferroptosis and other related biological characteristics of lung adenocarcinoma cell lines was detected.ResultsUpregulated SLC7A11 was shown in NSCLC patients and cells, and increased SLC7A11 had a relation to the poorly prognostic status of NSCLC patients. Besides, a novel miRNA, miR-27a-3p, was an essential modulator of ferroptosis via directly targeting SLC7A11 in NSCLC cells. Overexpressing miR-27a-3p led to SLC7A11 suppression via directly binding to its 3’-UTR, followed by the reduction of erastin-caused ferroptosis. In contrast, inhibited miR-27a-3p resulted in an increase in NSCLC cells’ sensitivity to erastin. Of importance, the accumulated lipid ROS and cell death of iron peptide mediated by anti-miR-27a-3p can be eliminated by impeding the glutamylation process. Our literature collectively uncovered that miR-27a-3p modulated ferroptosis by targeting SLC7A11 in NSCLC cells, illustrating the important role of miRNA in ferroptosis.ConclusionMiR-27a-3p modulates ferroptosis via targeting SLC7A11 in NSCLC cells, implying the significant role of miR-27a-3p/SLC7A11 in ferroptosis.


Sign in / Sign up

Export Citation Format

Share Document